Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-13 Purchase | 2023-12-14 08:11 am | ACELRX PHARMACEUTICALS INC | ACRX | Angotti Vincent J. Chief Executive Officer | 10,000 | $0.7268 | $7,268 | 101,805 (Direct) | View |
| 2023-09-11 Purchase | 2023-09-11 7:13 pm | ACELRX PHARMACEUTICALS INC | ACRX | Angotti Vincent J. Chief Executive Officer | 10,000 | $0.795 | $7,950 | 91,805 (Direct) | View |
| 2023-08-24 Sale | 2023-08-25 4:45 pm | ACELRX PHARMACEUTICALS INC | ACRX | Palmer Pamela P Chief Medical Officer | 16,956 | $1.1344 | $19,236 | 30,753 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-19 Other | 2024-03-21 4:30 pm | 2024-01-24 N/A | TALPHERA INC. | TLPH | Nantahala Capital Management LLC Harkey Wilmot B. Mack Daniel See remarks 10% Owner | 324,675 | $0 | 6,493,507 (Indirect) | View |
| 2024-03-15 Exercise | 2024-03-15 4:01 pm | 2024-03-15 2024-03-15 | TALPHERA INC. | TLPH | Nantahala Capital Management LLC Harkey Wilmot B. Mack Daniel See remarks 10% Owner | 755,000 | $0 | 1,992,519 (Indirect) | View |
| 2024-03-15 Exercise | 2024-03-15 4:01 pm | N/A N/A | TALPHERA INC. | TLPH | Nantahala Capital Management LLC Harkey Wilmot B. Mack Daniel See remarks 10% Owner | 755,000 | $5 | 1,992,519 (Indirect) | View |
| 2024-03-11 Option Award | 2024-03-12 6:39 pm | N/A N/A | TALPHERA INC. | TLPH | Angotti Vincent J. CHIEF EXECUTIVE OFFICER | 1,000 | $1.115 | 170,806 (Direct) | View |
| 2024-03-12 Option Award | 2024-03-12 6:39 pm | N/A N/A | TALPHERA INC. | TLPH | Angotti Vincent J. CHIEF EXECUTIVE OFFICER | 8,000 | $1.1244 | 170,806 (Direct) | View |
| 2024-03-03 Tax Withholding | 2024-03-04 8:57 pm | N/A N/A | TALPHERA INC. | TLPH | Dasu Badri N Chief Engineering Officer | 406 | $1.3 | 31,414 (Direct) | View |
| 2024-03-03 Tax Withholding | 2024-03-04 8:55 pm | N/A N/A | TALPHERA INC. | TLPH | Palmer Pamela P Chief Medical Officer | 450 | $1.3 | 59,149 (Direct) | View |
| 2024-03-03 Tax Withholding | 2024-03-04 8:54 pm | N/A N/A | TALPHERA INC. | TLPH | ASADORIAN RAFFI Chief Financial Officer | 558 | $1.3 | 37,733 (Direct) | View |
| 2024-03-03 Tax Withholding | 2024-03-04 8:53 pm | N/A N/A | TALPHERA INC. | TLPH | Angotti Vincent J. Chief Executive Officer | 1,623 | $1.3 | 161,806 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-27 9:06 pm | N/A 2034-02-13 | TALPHERA INC. | TLPH | Palmer Pamela P Chief Medical Officer | 126,000 | $0 | 161,344 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-27 9:04 pm | N/A 2034-02-13 | TALPHERA INC. | TLPH | Dasu Badri N Chief Engineering Officer | 102,667 | $0 | 119,820 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-27 9:01 pm | N/A 2034-02-13 | TALPHERA INC. | TLPH | ASADORIAN RAFFI Chief Financial Officer | 126,000 | $0 | 146,291 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-27 8:58 pm | N/A 2034-02-13 | TALPHERA INC. | TLPH | Angotti Vincent J. Chief Executive Officer | 410,667 | $0 | 505,429 (Direct) | View |
| 2024-02-10 Tax Withholding | 2024-02-13 9:46 pm | N/A N/A | TALPHERA INC. | TLPH | Dasu Badri N Chief Engineering Officer | 1,618 | $1.1 | 17,153 (Direct) | View |
| 2024-02-10 Tax Withholding | 2024-02-13 9:44 pm | N/A N/A | TALPHERA INC. | TLPH | Palmer Pamela P Chief Medical Officer | 1,602 | $1.1 | 35,344 (Direct) | View |
| 2024-02-10 Tax Withholding | 2024-02-13 9:42 pm | N/A N/A | TALPHERA INC. | TLPH | ASADORIAN RAFFI Chief Financial Officer | 1,790 | $1.1 | 20,291 (Direct) | View |
| 2024-02-10 Tax Withholding | 2024-02-13 9:40 pm | N/A N/A | TALPHERA INC. | TLPH | Angotti Vincent J. Chief Executive Officer | 7,043 | $1.1 | 94,762 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 06:03 am | 2023-07-20 2028-07-20 | TALPHERA INC. | TLPH | Nantahala Capital Management LLC Harkey Wilmot B. Mack Daniel See remarks 10% Owner | 4,411,766 | $0 | 10,580,598 (Indirect) | View |
| 2024-01-22 Disposition | 2024-01-24 06:03 am | 2023-07-20 2028-07-20 | TALPHERA INC. | TLPH | Nantahala Capital Management LLC Harkey Wilmot B. Mack Daniel See remarks 10% Owner | 4,411,766 | $0 | 10,580,598 (Indirect) | View |
| 2024-01-22 Option Award | 2024-01-24 06:03 am | 2024-01-24 N/A | TALPHERA INC. | TLPH | Nantahala Capital Management LLC Harkey Wilmot B. Mack Daniel See remarks 10% Owner | 6,168,832 | $0.769 | 10,580,598 (Indirect) | View |
| 2024-01-22 Option Award | 2024-01-23 5:22 pm | N/A 2034-01-22 | TALPHERA INC. | TLPH | JAIN ABHINAV Director | 6,099 | $0 | 6,099 (Direct) | View |
Ownership | 2024-01-22 06:01 am | N/A N/A | TALPHERA INC. | TLPH | Nantahala Capital Management LLC Harkey Wilmot B. Mack Daniel See remarks 10% Owner | 0 | $0 | 7,910,168 (Indirect) | View |
| 2023-10-10 Option Award | 2023-12-13 4:35 pm | 2024-10-10 2033-10-10 | ACELRX PHARMACEUTICALS INC | ACRX | HOFFMAN STEPHEN J Director | 4,068 | $0 | 5,905 (Direct) | View |
| 2023-10-10 Option Award | 2023-12-13 4:34 pm | 2024-10-10 2033-10-10 | ACELRX PHARMACEUTICALS INC | ACRX | Afable Richard Director | 4,068 | $0 | 5,955 (Direct) | View |
| 2023-10-10 Option Award | 2023-12-13 4:33 pm | 2024-10-10 2033-10-10 | ACELRX PHARMACEUTICALS INC | ACRX | WAN MARK A Director | 4,068 | $0 | 5,905 (Direct) | View |
| 2023-10-10 Option Award | 2023-12-13 4:25 pm | 2024-10-10 2033-10-10 | ACELRX PHARMACEUTICALS INC | ACRX | Bozilenko Marina Director | 4,068 | $0 | 6,093 (Direct) | View |
| 2023-10-10 Option Award | 2023-12-13 4:23 pm | 2024-10-10 2033-10-10 | ACELRX PHARMACEUTICALS INC | ACRX | Broadfoot Jill Marie Director | 4,068 | $0 | 5,593 (Direct) | View |
| 2023-10-10 Option Award | 2023-12-13 4:21 pm | 2024-10-10 2033-10-10 | ACELRX PHARMACEUTICALS INC | ACRX | Rosen Howard B Director | 4,068 | $0 | 8,780 (Direct) | View |
| 2023-10-10 Option Award | 2023-12-13 4:19 pm | 2024-10-10 2033-10-10 | ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director | 4,068 | $0 | 14,655 (Direct) | View |
| 2023-03-03 Tax Withholding | 2023-03-06 4:45 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | Dasu Badri N Chief Engineering Officer | 398 | $1.31 | 18,771 (Direct) | View |
| 2023-03-03 Tax Withholding | 2023-03-06 4:44 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | Palmer Pamela P Chief Medical Officer | 570 | $1.31 | 43,315 (Direct) | View |
| 2023-03-03 Tax Withholding | 2023-03-06 4:42 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 510 | $1.31 | 22,081 (Direct) | View |
| 2023-03-03 Tax Withholding | 2023-03-06 4:40 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | Angotti Vincent J. Chief Executive Officer | 1,703 | $1.31 | 63,836 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 4:26 pm | N/A 2033-02-09 | ACELRX PHARMACEUTICALS INC | ACRX | Palmer Pamela P Chief Medical Officer | 42,875 | $0 | 80,635 (Direct) | View |
| 2023-02-11 Tax Withholding | 2023-02-14 4:26 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | Palmer Pamela P Chief Medical Officer | 1,017 | $1.68 | 80,635 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 4:24 pm | N/A 2033-02-09 | ACELRX PHARMACEUTICALS INC | ACRX | Dasu Badri N Chief Engineering Officer | 34,125 | $0 | 48,419 (Direct) | View |
| 2023-02-11 Tax Withholding | 2023-02-14 4:24 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | Dasu Badri N Chief Engineering Officer | 776 | $1.68 | 48,419 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 4:22 pm | N/A 2033-02-09 | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 41,125 | $0 | 57,841 (Direct) | View |
| 2023-02-11 Tax Withholding | 2023-02-14 4:22 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 873 | $1.68 | 57,841 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 4:19 pm | N/A 2033-02-09 | ACELRX PHARMACEUTICALS INC | ACRX | Angotti Vincent J. Chief Executive Officer | 136,500 | $0 | 182,539 (Direct) | View |
| 2023-02-11 Tax Withholding | 2023-02-14 4:19 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | Angotti Vincent J. Chief Executive Officer | 3,321 | $1.68 | 182,539 (Direct) | View |
| 2023-02-06 Tax Withholding | 2023-02-08 4:51 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | Dasu Badri N Chief Engineering Officer | 458 | $2.02 | 15,070 (Direct) | View |
| 2023-02-06 Tax Withholding | 2023-02-08 4:48 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | ASADORIAN RAFFI Chief Financial Officer | 617 | $2.02 | 17,589 (Direct) | View |
| 2023-02-06 Tax Withholding | 2023-02-08 4:46 pm | N/A N/A | ACELRX PHARMACEUTICALS INC | ACRX | Palmer Pamela P Chief Medical Officer | 681 | $2.02 | 38,777 (Direct) | View |